United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund lifted its stake in McKesson Corporation (NYSE:MCK – Free Report) by 219.6% in the 4th quarter, Holdings Channel reports. The firm owned 11,504 shares of the company’s stock after purchasing an additional 7,904 shares during the quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s holdings in McKesson were worth $9,437,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. lifted its stake in shares of McKesson by 8.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 9,327 shares of the company’s stock valued at $7,650,000 after purchasing an additional 688 shares during the period. Jupiter Asset Management Ltd. lifted its stake in shares of McKesson by 4.7% in the fourth quarter. Jupiter Asset Management Ltd. now owns 101,442 shares of the company’s stock valued at $83,212,000 after purchasing an additional 4,521 shares during the period. Intech Investment Management LLC lifted its stake in shares of McKesson by 7.4% in the fourth quarter. Intech Investment Management LLC now owns 39,486 shares of the company’s stock valued at $32,390,000 after purchasing an additional 2,736 shares during the period. Foundations Investment Advisors LLC lifted its stake in shares of McKesson by 26.8% in the fourth quarter. Foundations Investment Advisors LLC now owns 2,956 shares of the company’s stock valued at $2,424,000 after purchasing an additional 625 shares during the period. Finally, Baker Avenue Asset Management LP lifted its stake in shares of McKesson by 13.2% in the fourth quarter. Baker Avenue Asset Management LP now owns 967 shares of the company’s stock valued at $793,000 after purchasing an additional 113 shares during the period. Institutional investors and hedge funds own 85.07% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently commented on MCK shares. UBS Group raised their price objective on shares of McKesson from $1,000.00 to $1,050.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Barclays increased their price objective on shares of McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research note on Wednesday, February 18th. Morgan Stanley reissued an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a research note on Thursday, January 29th. Mizuho increased their price objective on shares of McKesson from $880.00 to $885.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Finally, TD Cowen increased their price objective on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $968.87.
McKesson Trading Up 0.2%
Shares of NYSE MCK opened at $757.80 on Friday. The stock has a market cap of $91.09 billion, a price-to-earnings ratio of 19.70, a PEG ratio of 1.13 and a beta of 0.35. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00. The company’s 50-day moving average price is $823.51 and its 200 day moving average price is $853.22.
McKesson (NYSE:MCK – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $11.56 by $0.13. The company had revenue of $96.30 billion for the quarter, compared to analyst estimates of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The firm’s quarterly revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the firm earned $10.12 EPS. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. As a group, research analysts expect that McKesson Corporation will post 44.29 earnings per share for the current year.
McKesson Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be issued a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson’s dividend payout ratio is 8.53%.
Insider Transactions at McKesson
In other McKesson news, EVP Thomas L. Rodgers sold 2,388 shares of the company’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total value of $1,817,482.92. Following the transaction, the executive vice president directly owned 3,090 shares in the company, valued at approximately $2,351,768.10. This represents a 43.59% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Michele Lau sold 3,550 shares of the company’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the completion of the transaction, the executive vice president owned 3,247 shares in the company, valued at approximately $2,471,259.23. This trade represents a 52.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 8,663 shares of company stock worth $7,217,102. 0.08% of the stock is owned by insiders.
McKesson Company Profile
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
See Also
- Five stocks we like better than McKesson
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
